JPRN-UMIN000020032已完成未知
Intrathecal 2-hydroxypropyl-beta-cyclodextrin (HPBCD) therapy in adult-onset Niemann-Pick disease type C (NPC) - IT-HPBCD therapy in adult-onset NPC
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Infantile and child NPC 2) CNS or systemic infection 3) Without neurological involvement
研究者
相似试验
已完成
1 期
A phase1 study of Hydroxypropyl-beta-cyclodextrin(HP-beta-CyD)-adjuvanted influenza split vaccineinfluenza virus infectionJPRN-UMIN000028530Osaka University hospital36
进行中（未招募）
1 期
HELIOX-DRIVEN BETA2-AGONISTS NEBULIZATION FOR CHILDREN WITH MODERATE TO SEVERE ACUTE ASTHMA: A RANDOMIZED CONTROLLED TRIAModerate to severe exacerbations of asthmaMedDRA version: 19.0Level: PTClassification code 10064823Term: Asthmatic crisisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2015-004959-50-ESS.E. Carburos Metálicos S.A. grupo Air Products54
已完成
1 期
Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 DiseaseNiemann-Pick Disease, Type C1NCT01747135Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company14
尚未招募
不适用
A Clinical Trial to Compare the Effects of Nalbuphine and Dexmedetomidine along with Bupivacaine and Bupivacaine alone for Spinal Anaesthesia in Patients undergoing Orthopaedic SurgeriesCTRI/2022/03/041142Dr Vinay B R
进行中（未招募）
1 期
ONCOFID-P-B, a new anticancer drug for the treatment of bladder cancerMale and females patients affected by multiple primary and recurrent Ta G1-G2 papillary cancer of the bladder will be inlcuded in the study.MedDRA version: 18.1Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-012274-13-DEFidia Farmaceutici S.p.A60